Skip to main content
. 2024 Mar 12;15:2219. doi: 10.1038/s41467-024-46554-8

Fig. 4. The future outlook of NDs-on-a-chip for drug development.

Fig. 4

a Patient-derived pluripotent stem cells can provide relevant insights into ND pathophysiology. b 3D culture-on-a-chip combines the in vivo relevant characteristics of patient-derived 3D cultures (neurospheroids, organoids, and assembloids) and the unique engineering possibilities of microfluidic chips that can model interconnected brain regions and multi-organs. c Microfluidic-based, patient-derived in vitro ND models will contribute to drug discovery and preclinical drug development studies by replacing the animal models with the promise of personalised treatment. ND neurodegenerative disease.